6
Participants
Start Date
May 31, 2009
Primary Completion Date
September 30, 2011
Study Completion Date
September 30, 2011
Aminolevulinic Acid
20% aminolevulinic acid HCL (ALA) applied topically for 90 +/- 30 minutes prior to treatment with 10 j/cm2 blue light. Up to nine (9) ALA-PDT treatments will be given: The initial four (4) treatments will be given at 4-5 week intervals, with the remaining five (5) treatments given every 6 +/-1 weeks.
Vehicle
Vehicle ingredients only (VEH) applied topically for 90 +/- 30 minutes prior to treatment with 10 j/cm2 blue light. Up to nine (9) VEH-PDT treatments will be given: The initial four (4) treatments will be given at 4-5 week intervals, with the remaining five (5) treatments given every 6 +/-1 weeks.
The Mount Sinai Medical Center, New York
Fox Chase Cancer Center, Philadelphia
University of Miami, Miami
Vanderbilt University Medical Center, Nashville
University of California, Irvine, Irvine
University of California, San Francisco, San Francisco
Tufts Medical Center, Boston
Lead Sponsor
DUSA Pharmaceuticals, Inc.
INDUSTRY